fiduxosin has been researched along with orlistat in 2 studies
Studies (fiduxosin) | Trials (fiduxosin) | Recent Studies (post-2010) (fiduxosin) | Studies (orlistat) | Trials (orlistat) | Recent Studies (post-2010) (orlistat) |
---|---|---|---|---|---|
14 | 3 | 5 | 1,432 | 274 | 539 |
Protein | Taxonomy | fiduxosin (IC50) | orlistat (IC50) |
---|---|---|---|
Phosphatidylserine lipase ABHD16A | Homo sapiens (human) | 0.1 | |
Pancreatic triacylglycerol lipase | Sus scrofa (pig) | 0.4214 | |
Lipoprotein lipase | Homo sapiens (human) | 0.066 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.42 | |
Hepatic triacylglycerol lipase | Homo sapiens (human) | 0.003 | |
Pancreatic triacylglycerol lipase | Homo sapiens (human) | 0.3253 | |
Translocator protein | Rattus norvegicus (Norway rat) | 1 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.42 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.1903 | |
Fatty acid synthase | Homo sapiens (human) | 2.99 | |
Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.01 | |
Platelet-activating factor acetylhydrolase | Homo sapiens (human) | 0.05 | |
Diacylglycerol lipase-alpha | Mus musculus (house mouse) | 0.02 | |
Lysophosphatidylserine lipase ABHD12 | Homo sapiens (human) | 0.1682 | |
Diacylglycerol lipase-beta | Homo sapiens (human) | 0.24 | |
Monoacylglycerol lipase ABHD6 | Homo sapiens (human) | 0.03 | |
Acyl-protein thioesterase 2 | Rattus norvegicus (Norway rat) | 0.17 | |
Diacylglycerol lipase-alpha | Homo sapiens (human) | 0.2677 | |
Endothelial lipase | Homo sapiens (human) | 0.006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for fiduxosin and orlistat
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fiduxosin and orlistat
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |